Acquisition highlights of GenePath Dx and a snapshot of its key metrics.

Founded in 2012, GenePath Dx operates in Health Tech offering state-of-the-art clinical in vitro diagnostic services and developing novel next generation diagnostic tests for the global market. The company focuses on innovation and continuous research and development, adapting to global advancements and responding to emerging pathogens or rare genetic disorders. GenePath Dx collaborates closely with clinicians to create custom solutions for diagnostic challenges. The company prioritises its culture, guided by its core values and principles.

Nikhil Phadke

Funding highlights of GenePath Dx and a snapshot of its key metrics.

Snow Leopard Technology Ventures

Saama Capital

Investment highlights of GenePath Dx and a snapshot of its key metrics.

GenePath Dx

A snapshot of highlights, scale, and metrics

An overview of key people in GenePath Dx.

A Health Tech Funded Company Based Out Of Ann Arbor

Decoding financial health metrics of GenePath Dx

GenePath Dx - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More

GenePath Dx: Financial Breakdown

Disclaimer